Literature DB >> 5541925

Tanapox: a new disease caused by a pox virus.

A W Downie, C H Taylor-Robinson, A E Caunt, G S Nelson, P E Manson-Bahr, T C Matthews.   

Abstract

Two epidemics of a new virus disease, tanapox, occurred in 1957 and 1962 among the Wapakomo tribe along the Tana River in Kenya. Several hundred people were affected by a short febrile illness with headache and prostration and the disease was characterized by a single pock-like lesion on the upper part of the body. A pox virus, unrelated to the vaccinia-variola group, has been incriminated as the causative agent. The virus has a limited host range and has been grown only in human and monkey tissue cultures, and so far the only animals that have proved susceptible in the laboratory have been monkeys. The characteristic lesions have been reproduced in a human volunteer. Histopathological and electron microscopic studies indicate that the virus belongs to the pox group, but serological tests show that it differs from other animal pox viruses, including yabapox virus of monkeys. A similar if not identical pox virus has caused epidemics in primate colonies in the U.S.A. It is suggested that tanapox is a zoonosis and that the disease is transmitted from monkeys to man in Kenya.

Entities:  

Mesh:

Year:  1971        PMID: 5541925      PMCID: PMC1795031          DOI: 10.1136/bmj.1.5745.363

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  3 in total

1.  Electron microscopy of a benign epidermal pox disease of rhesus monkeys.

Authors:  H W Casey; J M Woodruff; W I Butcher
Journal:  Am J Pathol       Date:  1967-09       Impact factor: 4.307

2.  A contagious pox disease in monkeys.

Authors:  A S Hall; W P McNulty
Journal:  J Am Vet Med Assoc       Date:  1967-10-01       Impact factor: 1.936

3.  A pox disease in monkeys transmitted to man. Clinical and histological features.

Authors:  W P McNulty; W C Lobitz; F Hu; C A Maruffo; A S Hall
Journal:  Arch Dermatol       Date:  1968-03
  3 in total
  23 in total

1.  Tanapox. A serological survey of the lower Tana River Valley.

Authors:  J S Axford; A W Downie
Journal:  J Hyg (Lond)       Date:  1979-10

2.  Human tanapox in Zaire: clinical and epidemiological observations on cases confirmed by laboratory studies.

Authors:  Z Jezek; I Arita; M Szczeniowski; K M Paluku; K Ruti; J H Nakano
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

3.  Tanapoxvirus lacking a neuregulin-like gene regresses human melanoma tumors in nude mice.

Authors:  Tiantian Zhang; Yogesh R Suryawanshi; Dennis H Kordish; Helene M Woyczesczyk; David Jeng; Karim Essani
Journal:  Virus Genes       Date:  2016-10-13       Impact factor: 2.332

4.  Serological evidence of infection with Tana and Yaba pox viruses among several species of monkey.

Authors:  A W Downie
Journal:  J Hyg (Lond)       Date:  1974-04

Review 5.  Monkeypox virus.

Authors:  C T Cho; H A Wenner
Journal:  Bacteriol Rev       Date:  1973-03

6.  Differential susceptibility of human cancer cell lines to wild-type tanapoxvirus infection.

Authors:  Hui Lin Lee; Karim Essani
Journal:  Open Virol J       Date:  2010-04-08

Review 7.  Nonhuman primate dermatology: a literature review.

Authors:  Joseph A Bernstein; Peter J Didier
Journal:  Vet Dermatol       Date:  2009-06       Impact factor: 1.589

8.  The effect of antimicrobial feed additives on the colonization of the alimentary tract of chickens by Salmonella typhimurium.

Authors:  H W Smith; J F Tucker
Journal:  J Hyg (Lond)       Date:  1978-04

9.  The tanapoxvirus 15L protein is a virus-encoded neuregulin that promotes viral replication in human endothelial cells.

Authors:  David Jeng; Zhenzhong Ma; John W Barrett; Grant McFadden; Jeffrey A Loeb; Karim Essani
Journal:  J Virol       Date:  2012-12-26       Impact factor: 5.103

Review 10.  Poxviruses and the evolution of host range and virulence.

Authors:  Sherry L Haller; Chen Peng; Grant McFadden; Stefan Rothenburg
Journal:  Infect Genet Evol       Date:  2013-10-24       Impact factor: 3.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.